Balancing Sustainability and Access: The Future of Off-Patent Medicines
The off-patent medicines industry is a cornerstone of European healthcare, accounting for 70% of medicines dispensed in Europe. These drugs treat a range of severe conditions, including cancer, respiratory diseases, and autoimmune disorders, forming an essential part...
Royal College of Physicians Green Physician Toolkit: what can be learnt from listening to the public and patients
The Royal College of Physicians published a Green Physician Toolkit with the aim of supporting physicians to take action on climate change. Its publication was met with a backlash in some media, including reports that implementing such recommendations could compromise...
Decarbonisation of CKD treatment in the UAE
Decarbonisation of CKD treatment in the UAE. A discussion paper. It is recognised that global health and care systems are undergoing transformative change to adapt to the needs of patients and communities, with increasing pressure to be financially, socially and...
The E in ESG: Activity-Based Strategies Can Address Climate Impact Of Clinical Research
A partnership approach is required to reduce greenhouse gas emissions generated by pharma clinical studies. That is the advice in a guest contribution by the Sustainable Healthcare Coalition and Johnson & Johnson Innovative Medicine (formerly Janssen...